Non-Invasive Optical Sensor for Blood Volume and Sodium Monitoring

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for monitoring blood parameters during extracorporeal blood treatments, such as hemodialysis, are invasive, costly, and lack accuracy, particularly for real-time measurement of relative blood volume variation (ΔRBV) and plasma sodium concentration (Napl), which are crucial for optimizing treatment efficacy and patient safety.

Innovation Solution

A non-invasive sensor system that uses multiple detectors and a controller to determine blood volume variation and plasma sodium concentration by analyzing light signals transmitted through the blood, employing state-space mathematical modeling and Kalman filtering to provide continuous, accurate measurements without the need for blood sampling or perturbation of the dialysate circuit.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If invasive methods are used to measure blood parameters, then measurement precision may be improved, but ease of operation deteriorates and loss of time increases

Engineering Contradiction:
Improveblood parameter measurement accuracyVSAvoidoperational simplicity
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent replaces invasive mechanical blood sampling with non-invasive optical measurement. The sensor system uses light sources and detectors to measure blood parameters (ΔRBV, Napl) through the skin and extracorporeal circuit without requiring blood draws, thereby maintaining measurement precision while dramatically improving ease of operation and eliminating procedural complexity

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces an optical intermediary system consisting of light sources, detectors, and mathematical modeling (state-space models with Kalman filtering) that mediates between the blood parameters and the measurement device. This intermediary optical system enables accurate non-invasive measurement by converting biological parameters into detectable optical signals

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If blood sampling is performed frequently, then measurement precision improves, but loss of time increases and productivity decreases

Engineering Contradiction:
Improvereal-time parameter accuracyVSAvoidtreatment efficiency
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent implements continuous real-time monitoring of blood parameters throughout the treatment session. The sensor system continuously measures ΔRBV and Napl without interruption, eliminating the need for discrete sampling events. This continuous measurement approach maintains high measurement precision while maximizing treatment productivity by eliminating time lost to repeated blood draws and laboratory analysis

Inventive Principle:
Principle #20Continuity of useful action

3Measurement precision

If complex measurement systems are used, then measurement precision improves, but device complexity increases

Engineering Contradiction:
Improveparameter determination accuracyVSAvoidsystem structural complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces complex invasive measurement systems with a simpler non-invasive optical system. By using light-based measurement through the skin and extracorporeal circuit, the system achieves accurate blood parameter measurement without complex blood sampling infrastructure, laboratory equipment, or invasive catheters, thereby reducing overall device complexity while maintaining precision

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Measurement precision

If invasive measurement methods are used, then measurement precision may be improved, but object-affected harmful factors increase

Engineering Contradiction:
Improveblood parameter accuracyVSAvoidpatient risk and discomfort
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent substitutes invasive mechanical blood sampling with non-invasive optical measurement, thereby eliminating harmful factors associated with needle sticks, infection risk, blood loss, and patient discomfort. The optical sensor system measures blood parameters through the skin and extracorporeal circuit without penetrating the body, completely removing these harmful effects while maintaining measurement precision

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent enables the measurement system to function without requiring blood extraction or laboratory processing. The optical sensor system performs self-contained measurement of blood parameters directly at the patient site, eliminating the need for external laboratory services and reducing associated risks and harms

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables real-time, accurate monitoring of ΔRBV and Napl, allowing for improved treatment optimization and patient safety by providing continuous, non-invasive, and cost-effective measurement of blood parameters during extracorporeal treatments.

Implementation Method 1

uses multiple detectors and a controller to determine blood volume variation and plasma sodium concentration by analyzing light signals transmitted through the blood

Methodology Applied
Scientific EffectLight transmission and absorption: Absorption (EM radiation)

Data Source

PatentUS20240350040A1Apparatus, sensor and process for determining at least one parameter of blood circulating in an extracorporeal blood circuit
Publication Date: 2024.10.24 GAMBRO LUNDIA AB
  • US20240350040A1 patent drawing
  • US20240350040A1 patent drawing
  • US20240350040A1 patent drawing

AI summary

An apparatus for extracorporeal treatment of blood comprising a treatment unit, a blood withdrawal line, a blood return line, a preparation line and a spent dialysate line; a non-invasive blood volume sensor for determining an additional property of blood is active on a tube segment of the blood withdrawal line or of the blood return line; the sensor includes one source for directing a signal towards the blood, a plurality of detectors for receiving the signal, and a controller receiving the output signals from the detectors and determining a blood volume variation and a value of sodium concentration in the blood (NaPl) both based on the output signals. A process of determining at least one parameter and on property of blood circulating an extracorporeal blood circuit is also disclosed.